SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-008829
Filing Date
2018-02-14
Accepted
2018-02-14 15:38:54
Documents
1
Group Members
MARK WANTHREE ARCH ASSOCIATES III, L.P.THREE ARCH ASSOCIATES IV, L.P.THREE ARCH MANAGEMENT III, L.L.C.THREE ARCH MANAGEMENT IV, L.L.C.THREE ARCH PARTNERS III, L.P.WILFRED JAEGER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv485568_sc13da.htm SC 13D/A 110159
  Complete submission text file 0001144204-18-008829.txt   111740
Mailing Address
Business Address 3200 ALPINE ROAD PORTOLA VALLEY CA 94028 6176191737
THREE ARCH PARTNERS IV LP (Filed by) CIK: 0001269801 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Subject) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86112 | Film No.: 18611865
SIC: 2834 Pharmaceutical Preparations